Home Medix HM-KV 5 LPM vs Yuwell 8F

A standalone mid-tier concentrator against a combined concentrator-plus-nebulizer

The Home Medix HM-KV 5 LPM and the Yuwell 8F with built-in nebulizer compete on different propositions. The HM-KV is a focused 5 LPM home-stationary concentrator at ₹37,800 with class-leading sound and a published 3-year / 10,000-hour warranty. The Yuwell 8F bundles an integrated nebulizer outlet alongside the 5 LPM concentrator chassis at a listed price of ₹20,000 (listed MRP ₹43,200) — less than half the HM-KV’s sticker.

The ₹20,000 listing price is suspiciously low for a 5 LPM concentrator-plus-nebulizer combo from a top-tier Chinese OEM. The MRP of ₹43,200 on the same listing is the more typical retail band for this class. Two readings: (a) the listing reflects a genuine price drop (year-end run-out, Indian-importer clearance ahead of a model refresh, or e-commerce promotion), in which case the Yuwell 8F is an exceptional value pick; (b) the listing is mispriced or covers an older / refurbished unit, in which case the buyer should verify before relying on the spec. We accept the ₹20,000 figure as published on the data sheet but flag it for buyer verification.

The right framing for this comparison is which household profile needs an integrated nebulizer alongside the concentrator — asthma plus COPD overlap, post-bronchitis recovery, paediatric reactive-airway with a parent on LTOT, or care-giver-shared multi-condition households — versus which household is better served by a dedicated concentrator plus a separate standalone nebulizer.

At-a-glance differences

• Price: Yuwell 8F ₹20,000 (listed MRP ₹43,200) vs HM-KV ₹37,800 (listed MRP ₹54,000) — Yuwell 8F is ₹17,800 cheaper at current retail; verify pricing at purchase
• Weight: HM-KV 13 kg vs Yuwell 8F 15.5 kg — HM-KV is 2.5 kg lighter (16% less)
• Sound: HM-KV ≤ 40 dB(A) field-verified; Yuwell 8F 52 dB per data sheet — 12 dB louder, perceptually roughly 2.3× as loud at bedside
• Oxygen flow: Both 0.5–5 L/min continuous
• Oxygen concentration: HM-KV 93% ± 3%; Yuwell 8F 90–95% (same practical band)
• Power: HM-KV 320 VA at AC 230V ±10% tolerance (207–253 V documented); Yuwell 8F 400 W with no published AC tolerance band
• Outlet pressure: Yuwell 8F 10 psi; HM-KV 0.04–0.06 MPa (≈ 5.8–8.7 psi)
• Integrated nebulizer port: Yuwell 8F — Yes (this is the unit’s defining feature); HM-KV — Yes (Integrated Nebulization listed in Home Medix differentiators), though without a separate nebulizer-bundle SKU framing
• Oxygen Purity Indicator / Analyzer: HM-KV documents both; Yuwell 8F data sheet lists neither
• Alarm suite: HM-KV documents Loss of Power, System Malfunction (High Temp), and Low/No Flow; Yuwell 8F documents Loss of Power and System Malfunction (No-Flow alarm field left blank)
• Warranty: HM-KV 3 years or 10,000 hours (whichever comes first); Yuwell 8F does not publish a warranty term — typical Indian-importer terms are 1–2 years
• Regulatory: HM-KV — CDSCO approved, ISO 9001, ISO 13485 documented. Yuwell 8F — Indian-voltage; CDSCO / ISO / CE / FDA fields not populated on the visible data sheet
• Customer rating: Yuwell 8F shows 4.3 from 22 reviews on the e-commerce listing; HM-KV does not show a rating count on the equivalent field
• Stock status: Both In Stock at current snapshot

Where the Yuwell 8F wins

Price — ₹17,800 cheaper. At ₹20,000 vs ₹37,800, the Yuwell 8F is 47% below the HM-KV — a genuinely large gap. Even at the listed MRP of ₹43,200, the unit lands in the lower mid-tier of the Indian 5 LPM market. If the listing price is the actual retail point (and not a mispricing artefact), the unit is a value-tier outlier worth the buyer’s verification effort.

Integrated nebulizer as a defining feature. The Yuwell 8F’s USP is the built-in nebulizer outlet, allowing the patient to run a nebulized bronchodilator or steroid alongside concentrator-delivered oxygen from a single chassis. For an asthma-plus-COPD overlap patient who needs both salbutamol nebulizations and continuous oxygen during an exacerbation, the integrated workflow is operationally cleaner than juggling two separate devices on a bedside table. The HM-KV does list “Integrated Nebulization: Yes” in its differentiators section, but the Yuwell 8F is more explicitly marketed as a combo unit at a price point that bundles both functions (GOLD Report).

Customer-reported rating data on the listing. The Yuwell 8F shows 4.3 from 22 reviews on the e-commerce channel. This is a small sample and not a substitute for a clinical evaluation, but it is more on-listing user-feedback data than the HM-KV’s listing shows. For buyers who weight crowd-rating signal, this is a mild plus.

10 psi outlet pressure. Yuwell 8F publishes 10 psi at outlet vs the HM-KV’s 5.8–8.7 psi range. For long cannula runs or nebulizer-loop setups with extra hose, more outlet headroom helps.

Manageable weight relative to other Yuwell SKUs. At 15.5 kg, the Yuwell 8F is substantially lighter than the Yuwell 7F (27 kg) and similar to the typical mid-tier 5 LPM weight. It is heavier than the HM-KV but not in two-person-carry territory.

Where the HM-KV wins

Sound — ≤ 40 dB vs 52 dB. A 12 dB gap is two perceptual doublings of loudness. The Yuwell 8F’s 52 dB is roughly bedside-conversation volume — usable for short nebulization sessions during the day, intrusive for nocturnal continuous LTOT. For a patient running 16 hours a day of oxygen with intermittent nebulization, the HM-KV’s quieter chassis is the better long-term bedside neighbour.

Weight — 13 kg vs 15.5 kg. A 2.5 kg margin matters for the same single-person-carry / multi-room-relocation reasons noted in the other comparisons in this set.

Documented OPI and percent analyzer. HM-KV publishes both; Yuwell 8F data sheet lists neither. For monitoring sieve-bed health over the long warranty window, the HM-KV’s OPI is meaningful.

Documented No-Flow alarm. HM-KV publishes all three standard alarms. Yuwell 8F publishes two — power and system — but leaves the No-Flow field blank. For nocturnal use, the No-Flow alarm is the safety-critical alert.

Documented AC ±10% voltage tolerance. HM-KV publishes the 207–253 V envelope. Yuwell 8F publishes 400 W without a tolerance band.

3-year / 10,000-hour published warranty. HM-KV publishes both wall-clock and operating-hour ceilings. Yuwell 8F’s listing does not publish a warranty term.

Indian-HQ service and CDSCO documentation. HM-KV documents CDSCO approval, ISO 9001, and ISO 13485. Yuwell 8F’s data sheet does not populate these fields on the visible listing, though CDSCO status may exist through the importer.

Pricing caveat and verification

The Yuwell 8F’s ₹20,000 listing price is the lowest documented figure across the comparisons in this set, and it sits notably below the Owgels 5L’s ₹28,608 (a budget Chinese-OEM 5 LPM with no integrated nebulizer). The combination of a built-in nebulizer at a sub-Owgels price is unusual. Possible explanations: (a) genuine importer clearance / end-of-line promotion; (b) refurbished or older-stock unit listed at a clearance price; (c) listing-price error not yet corrected. The MRP on the same listing is ₹43,200 — in the band you would expect for a Yuwell mid-tier combo. We document the published price as the data-of-record but flag it for verification at purchase, particularly around (i) whether the unit is new or refurbished, (ii) whether the importer warranty fully applies at this price, and (iii) the realistic post-warranty service trajectory at this listing.

Indian-market considerations

The right buyer for an integrated nebulizer. Asthma-plus-COPD overlap is a real and increasingly common clinical phenotype — older adults with longstanding asthma develop a COPD-like component over time and need both bronchodilator therapy and supplemental oxygen, sometimes within the same care episode (GOLD Report). Post-acute bronchitis recovery, paediatric reactive-airway in a household with a parent on LTOT, and post-discharge multi-condition home care also benefit from a combined chassis. For these profiles, the integrated nebulizer port is a workflow win, not a marketing add-on.

The wrong buyer for an integrated nebulizer. A patient on simple supplemental oxygen with no nebulization prescription pays for a feature they do not use. A standalone nebulizer at ₹1,500–₹2,500 covers most paediatric or low-frequency adult use cases without needing the integrated unit. If the household’s nebulization frequency is “once or twice a year for an upper-respiratory event,” a dedicated concentrator (HM-KV) plus a cheap standalone nebulizer is operationally cleaner and avoids tying the nebulizer to the concentrator’s service downtime windows.

Stabiliser sizing. HM-KV at 320 VA wants a 500 VA stabiliser minimum. Yuwell 8F at 400 W (≈ 470 VA at 0.85 PF) wants a 750 VA stabiliser. Both are stabiliser-mandatory in Tier-2/Tier-3 mains.

Altitude. Neither data sheet publishes an altitude ceiling for the 8F; HM-KV also does not publish one. Hill-station installs warrant in-use purity verification regardless of unit.

GST. 12% GST applies to both.

Who should pick which

Pick the Yuwell 8F (with Nebulizer) if: the patient has documented asthma-plus-COPD overlap or any clinical phenotype requiring routine nebulization alongside continuous supplemental oxygen, where the integrated chassis is a real workflow win; the household has multiple respiratory-care users (e.g., a COPD parent on oxygen plus a child with reactive-airway disease) sharing a single device; the listing price of ₹20,000 is verified as genuine new-stock with full importer warranty; the 52 dB sound floor and 2.5 kg of extra weight are acceptable trade-offs for the integrated nebulizer and the ₹17,800 sticker saving.

Pick the Home Medix HM-KV 5 LPM if: the prescription is simple supplemental oxygen with no recurrent nebulization need; the unit will be at the patient’s bedside for nocturnal LTOT use where 12 dB quieter is the difference between sleep-acceptable and not; you want documented OPI, percent analyzer, full three-alarm coverage, AC ±10% voltage tolerance, and a 3-year / 10,000-hour warranty framework; you would rather buy a dedicated concentrator plus a separate standalone nebulizer (₹1,500–₹2,500) for the infrequent use case than tie both functions to one chassis with one service-downtime window.

Verdict

This is a use-case-dependent split, not a winner by knockout. The Yuwell 8F at ₹20,000 — if verified as a genuine new-stock listing — is a legitimate value pick for households needing both therapies in the same chassis, and the integrated nebulizer port is a real workflow benefit for asthma+COPD overlap, paediatric-plus-LTOT-parent, and post-bronchitis-recovery profiles. The HM-KV is the better standalone 5 LPM concentrator on every spec axis except outlet pressure, and the better choice for nocturnal LTOT use where bedside sound, alarm coverage, and warranty depth dominate.

The honest summary: if you need an integrated nebulizer and the Yuwell listing price holds, buy the Yuwell 8F. If you do not need an integrated nebulizer, or if you would rather decouple the two devices for service-resilience reasons, buy the HM-KV and a separate ₹2,000 nebulizer.

Consult your treating pulmonologist before finalising the prescription — flow titration and nebulization frequency drive the clinical decision; the chassis comparison only matters after both are right.